| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 221.16B | 219.61B | 211.53B | 212.82B | 206.01B | 175.65B |
| Gross Profit | 37.85B | 36.94B | 34.80B | 33.58B | 33.89B | 30.48B |
| EBITDA | 17.95B | 17.33B | 15.81B | 14.82B | 15.50B | 13.36B |
| Net Income | 6.60B | 6.51B | 5.31B | 5.25B | 5.98B | 4.89B |
Balance Sheet | ||||||
| Total Assets | 208.98B | 206.82B | 213.37B | 195.38B | 190.02B | 179.74B |
| Cash, Cash Equivalents and Short-Term Investments | 14.98B | 21.00B | 18.13B | 15.02B | 16.70B | 14.05B |
| Total Debt | 70.18B | 68.51B | 74.23B | 71.16B | 68.93B | 62.79B |
| Total Liabilities | 115.79B | 113.45B | 124.16B | 114.67B | 113.89B | 108.53B |
| Stockholders Equity | 92.45B | 92.73B | 88.62B | 80.20B | 75.66B | 70.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.80B | 4.05B | -2.42B | -994.00M | 1.33B |
| Operating Cash Flow | 0.00 | 18.14B | 11.12B | 7.01B | 16.70B | 11.07B |
| Investing Cash Flow | 0.00 | -8.26B | -9.29B | -9.39B | -18.22B | -13.45B |
| Financing Cash Flow | 0.00 | -7.05B | 1.05B | 535.00M | 4.12B | 5.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥101.64B | 7.99 | 7.53% | 3.01% | 5.44% | 45.99% | |
76 Outperform | ¥12.88B | 8.51 | ― | 1.20% | 6.42% | -6.32% | |
74 Outperform | ¥79.43B | 12.05 | ― | 6.64% | 2.85% | -9.13% | |
73 Outperform | ¥56.41B | 5.78 | ― | 3.31% | 0.83% | -9.16% | |
68 Neutral | ¥55.88B | 5.57 | ― | 3.50% | 4.40% | 47.13% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥18.89B | 21.58 | ― | 4.39% | 5.06% | -15.22% |